HiroyuHatanoMD
Internal Medicine • Palo Alto, CAInfectious Disease
Assistant Professor, Medicine, University of California, San Francisco, School of Medicine
Are you Dr. Hatano?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 41 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
3200 Middlefield Rd
Ste C
Palo Alto, CA 94306Phone+1 650-850-4111Fax+1 650-666-8219
Summary
- Dr. Hiroyu Hatano, MD is a board certified internist in Palo Alto, California. She is currently licensed to practice medicine in California and Massachusetts. She is affiliated with Stanford Health Care and is an Assistant Professor at University of California.
Education & Training
University of California (San Francisco)Fellowship, Infectious Disease, 2004 - 2007
Brigham and Women's HospitalResidency, Internal Medicine, 2001 - 2004
Stanford University School of MedicineClass of 2001
Certifications & Licensure
CA State Medical License 2004 - 2026
MA State Medical License 2003 - 2006- American Board of Internal Medicine Internal Medicine
Clinical Trials
- Raltegravir Intensification in HIV-infected Patients Start of enrollment: 2008 Feb 01
- HIV Persistence and Viral Reservoirs Start of enrollment: 2009 Dec 01
- The Use of Leukapheresis to Support HIV Pathogenesis Studies Start of enrollment: 2010 Oct 26
- Join now to see all
Publications & Presentations
PubMed
- 81 citationsPre-HAART HIV burden approximates post-HAART viral levels following interruption of therapy in patients with sustained viral suppression.Hiroyu Hatano, S Vogel, Christian Yoder, Julia A. Metcalf, Robin Dewar
AIDS. 2000-07-07 - 839 citationsCell death by pyroptosis drives CD4 T-cell depletion in HIV-1 infectionGilad Doitsh, Nicole L. K. Galloway, Xin Geng, Zhiyuan Yang, Kathryn M. Monroe
Nature. 2014-01-23 - 448 citationsHIV-infected individuals with low CD4/CD8 ratio despite effective antiretroviral therapy exhibit altered T cell subsets, heightened CD8+ T cell activation, and increas...Sergio Serrano-Villar, Talía Sainz, Sulggi A. Lee, Peter W. Hunt, Elizabeth Sinclair
Plos Pathogens. 2014-05-15
Grant Support
- Virologic And Host Factors Contributing To HIV Control In Elite ControllersNational Institute Of Allergy And Infectious Diseases2007–2011
